AnticoagEvaluator
9.8 6
About AnticoagEvaluator
AnticoagEvaluator (Package Name: org.acc.AnticoagEvaluatorV2) is developed by American College of Cardiology Foundation and the latest version of AnticoagEvaluator 4.7 was updated on August 23, 2024. AnticoagEvaluator is in the category of Medical. You can check all apps from the developer of AnticoagEvaluator and find 200 alternative apps to AnticoagEvaluator on Android. Currently this app is for free. This app can be downloaded on Android 7.0+ on APKPure.fo or Google Play. All APK/XAPK files on APKPure.fo are original and 100% safe with fast download.
Make well-informed decisions on anti thrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for anti thrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
AnticoagEvaluator 4.7 Update
This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.
Read More
AnticoagEvaluator Features
Previous Versions
More
Requires Android: Android 7.0+
Screen DPI: 120-640dpi
SHA1: 530239554d6fdf31c70e9cec08b4e7df65c282f3
Size: 4.82 MB
What's New:
This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.
Requires Android: Android 7.0+
Screen DPI: 120-640dpi
SHA1: 027db124f12e2c6ef71531436af284f6a5ebad55
Size: 4.65 MB
What's New:
This update includes underlying architecture improvements and minor reference link updates.
Requires Android: Android 7.0+
Screen DPI: 120-640dpi
SHA1: c03c85fc1be73381a6b19c812a5d0135e13bd62f
Size: 4.65 MB
What's New:
This update includes underlying architecture improvements and minor reference link updates.
Requires Android: Android 4.0+
Screen DPI: 120-640dpi
SHA1: 2b8e6fdeace543cbbf2418870413ee3608313aa5
Size: 7.12 MB
What's New:
Updated warfarin dosing information
More Information
Package Name:
Update Date:
2024-08-23
Latest Version:
4.7
Need Update:
Available on:
Requirements:
Android 7.0+
Report:
Safe to Download
APKPure.fo and the download link of this app are 100% safe. All download links of apps listed on APKPure.fo are from Google Play Store or submitted by users. For the app from Google Play Store, APKPure.fo won't modify it in any way. For the app submitted by users, APKPure.fo will verify its APK signature safety before release it on our website.